+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating the effectiveness and safety of erythrocytapheresis in people with Chronic Mountain Sickness CMS. This condition affects residents living at high altitudes, and the study aims to compare outcomes between those receiving erythrocytapheresis plus standard care and those receiving standard care alone. The trial focuses on how well this blood cell removal procedure works as a method to reduce hematocrit levels and improve symptoms. Participants will be randomly assigned to one of two groups. The intervention group will receive erythrocytapheresis, which involves removing a set amount of red blood cells using a machine, while their plasma and other blood components are returned to maintain blood volume. Both groups will continue with standard care, including oxygen therapy and basic medical management. Clinical assessments will be conducted shortly after treatment and during follow-up to compare symptoms and physical function. Throughout the study, participants will undergo evaluations such as symptom scoring for CMS, the Incremental Shuttle Walk Test to measure exercise capacity, blood oxygen levels, and monitoring for any complications from the procedure. These assessments will occur 48 to 72 hours after erythrocytapheresis or prior to discharge for the standard care group, and then periodically during follow-up. The research team will use this data to understand the potential benefits and safety of erythrocytapheresis over time.

Age: 18Years +All GendersPhase Not Applicable
1 location
C

Actively Recruiting

Researchers are evaluating whether High-flow Nasal Cannula Oxygen Therapy HFNC offers better respiratory support than Conventional Oxygen Therapy COT in patients suffering from High-Altitude Pulmonary Edema HAPE. HAPE is a serious condition occurring at high altitudes, and while COT is the standard treatment, the effectiveness of HFNC in this specific context is not well understood. This study aims to clarify the role of HFNC in improving respiratory function and speeding recovery for HAPE patients. Participants are randomly assigned to one of two groups one receiving HFNC with a specialized system that includes active humidification and heated-wire circuits delivered through a wide nasal cannula, alongside standard medical care the other receiving COT plus standard medical care. The study compares these two oxygen therapies during the treatment period lasting around 3 to 5 days, with monitoring up to 7 days to assess treatment success and other health outcomes. During the study, participants undergo assessments such as lung CT scans, oxygen saturation monitoring, and evaluations of oxygen therapy-related complications. Researchers track the time to stop supplemental oxygen, changes in lung severity scores, and the proportion of treatment failures. Participants are observed from the start of treatment until discharge, with safety and treatment effectiveness measured closely throughout the approximately one-week study period.

Age: 18Years +All GendersPhase Not Applicable
1 location